Drug notes:
Also NDA errosive GERD, heartburn, Clin3 heartburn in non-erosive GERD, different dosing Clin2 heartburn in non-erosive GERD, Clin2 eosinophilic esophagitis
About:
Phathom Pharmaceuticals is dedicated to improving treatments for gastrointestinal (GI) diseases. They focus on developing innovative therapies for acid-related disorders like ulcers and heartburn. One key area of their research is the development of new proton pump inhibitors – a class of drugs that reduce stomach acid production. While there are existing PPIs on the market, Phathom is investigating more effective and potentially longer-lasting options. This could lead to improved patient outcomes and potentially reduce the need for frequent medication use.
Strategic Account Specialist -- MidwestStrategic Account Specialist -... Remote|1 day ago
Strategic Account Specialist - Northern PA/Lower N...Strategic Account Specialist -... Remote|5 days ago
Strategic Account Specialist - Northern PA/Lower N...Strategic Account Specialist -... Pennsylvania, United States|6 days ago
Associate Director Clinical OperationsAssociate Director Clinical Op... Buffalo Grove, IL|12 days ago
Territory Sales Representative - Johnstown PATerritory Sales Representative... Pennsylvania, United States|20 days ago
Territory Sales Representative - Hialeah FLTerritory Sales Representative... Florida, United States|Posting date unknown
Territory Sales Representative - Flushing New York...Territory Sales Representative... New York, NY|Posting date unknown
Strategic Account Specialist - South Central PA/No...Strategic Account Specialist -... Pennsylvania, United States|Posting date unknown